Search Results - A. N. Meshkov

Refine Results
  1. 1

    CLOPIDOGREL PHARMACOGENETICS by A. N. Meshkov

    Published 2016-01-01

    Platelets play an important role in the pathogenesis of atherosclerosis. They are involved in atherosclerosis progression and thrombotic complications. That is why antiplatelet therapy is a necessary element of these complications prevention in patients with coronary heart disease. One of the most c...

    Full description

    Get full text
    Article
  2. 2

    LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS by A. N. Meshkov

    Published 2015-12-01

    Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled clinical trials of the GALAXY program: COMETS, LUNAR, MERCURY-I, SOLAR, STELLAR.

    Get full text
    Article
  3. 3

    EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES by A. N. Meshkov

    Published 2016-01-01

    Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...

    Full description

    Get full text
    Article
  4. 4

    Hypertriglyceridemia: etiology, pathogenesis, diagnostics by T. V. Chepetova, A. N. Meshkov

    Published 2006-10-01

    The review is devoted to modern views on hypertriglyceridemia (HTG) etiology and pathogenesis, and its casual role in some disease development. Data on normal TG metabolism, main causes of HTG, its clinical role and diagnostics are discussed. Even though HTG plays an important role in atherosclerosi...

    Full description

    Get full text
    Article
  5. 5

    The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis by S. A. Smetnev, A. N. Meshkov

    Published 2015-11-01

    Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia in particular. The study of the causes and progression of atherosclerosis is a critical moment in the fight against CVD. Adipose tissue and processes that occur in it attracts attention in recent years. The i...

    Full description

    Get full text
    Article
  6. 6

    GENETICS FOR DIAGNOSTICS IN PREVENTIVE MEDICINE by I. V. Sidonets, A. N. Meshkov

    Published 2014-08-01

    The sequencing of first human genome followed by rapid development of technologies, that led to significant lowering of costs for genetic analyze and its fast performing, made possible a broad invention of genetic diagnostics methods into clinical practice. Contemporary methods of molecular genetics...

    Full description

    Get full text
    Article
  7. 7

    EXOME SEQUENCING AND THE DIAGNOSTICS OF COMPLEX DISEASE PREDISPOSITION IN PREVENTIVE MEDICINE by N. V. Shcherbakova, A. N. Meshkov, S. A. Boytsov

    Published 2013-12-01

    The further development of preventive medicine in the 21st century may be impossible without the assessment of individual patients’ genetic data. At present, genetic methods are the gold standard in the diagnostics of monogenic diseases. Recently, genetic factors linked to complex (multifactorial) d...

    Full description

    Get full text
    Article
  8. 8

    INFLUENCE OF SMOKING ON THE METHYLIZING STATUS OF DESOXYRIBONUCLEIC ACID by A. V. Kiseleva, A. A. Zharikova, A. N. Meshkov

    Published 2015-12-01

    Smoking is one of the main factors of a wide range of diseases as ischemic heart disease, stroke, chronic obstructive pulmonary disease. To know mechanisms of smoking influence on the course of these diseases might lead to discovery of novel methods of diagnostics and prevention. Recent studies show...

    Full description

    Get full text
    Article
  9. 9

    Preanalytical factors affecting the plasma and serum levels of circulating microRNAs by E. A. Sotnikova, A. V. Kiseleva, A. N. Meshkov

    Published 2025-01-01

    Circulating microribonucleic acids (microRNAs) are promising biomarkers of various diseases, but their clinical laboratory use requires highly sensitive, reproducible, reliable and sustainable methods for their accurate plasma and serum quantification. The preanalytical phase of studies conducted us...

    Full description

    Get full text
    Article
  10. 10

    Effect of plasma and serum storage conditions on circulating microRNA levels by E. A. Sotnikova, A. V. Kiseleva, A. N. Meshkov

    Published 2025-01-01

    Over the past decade, circulating small non-coding ribonucleic acid molecules (microRNAs) have demonstrated their potential as minimally invasive diagnostic and prognostic biomarkers of various diseases. Standardization of preanalytical and analytical factors, including collection, processing and st...

    Full description

    Get full text
    Article
  11. 11

    Hypertriglyceridemia — current status of the problem. Part I: risks, physiology and pathophysiological aspects, classification and diagnostic problems by A. A. Semenkin, A. N. Meshkov, M. V. Yezhov

    Published 2025-02-01

    Numerous studies demonstrate an independent relationship between an increase in the blood content of triglyceride-rich particles and the risk of atherosclerotic cardiovascular diseases and acute pancreatitis. This review article presents in detail aspects of the pathogenesis of various types of prim...

    Full description

    Get full text
    Article
  12. 12

    Hypertriglyceridemia — current status of the problem. Part II: primary and secondary hypertriglyceridemias, treatment options by A. A. Semenkin, A. N. Meshkov, M. V. Yezhov

    Published 2025-03-01

    Hypertriglyceridemias are a heterogeneous group of pathologies differing in the mechanisms of triglyceride-rich lipoprotein increase, the composition of lipoproteins and related risks. This review article presents information on the profile and pathogenesis of various primary and secondary hypertrig...

    Full description

    Get full text
    Article
  13. 13

    Modern ultrasound methods and atherosclerosis assessment in patients with familial hypercholesterolemia by A. I. Ershova, A. N. Meshkov, S. A. Boytsov, T. V. Balakhonova

    Published 2011-06-01

    Familial hypercholesterolemia (FHCH) is characterised by early atherosclerosis development and its fast progression. The prevalence of FHCH inRussiahas been increasing, therefore, it is important to evaluate the potential of various methods for atherosclerosis diagnostics. Arterial ultrasound is an...

    Full description

    Get full text
    Article
  14. 14

    THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 by S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov

    Published 2017-01-01

    Aim. To estimate the effectiveness of lipid-lowering therapy (LLT) at outpatient and hospital treatment stages in patients at high and very high cardiovascular risk during 2011-2015.Material and methods. In a cross-sectional epidemiological study we analyzed LLT in hospital patients for the period A...

    Full description

    Get full text
    Article
  15. 15

    Lifelong prevention of cardiovascular disease. Part I: preconceptional, prenatal and infant periods of life by O. V. Kopylova, A. I. Ershova, A. N. Meshkov, O. M. Drapkina

    Published 2020-12-01

    Current prophylactic actions prevent or significantly delay the majority of cardiovascular diseases (CVD). Various factors are interconnected and affect a person throughout his life, determining the risk of CVD. This indicates the need for preventive measures at all stages of life and even before bi...

    Full description

    Get full text
    Article
  16. 16

    Familial defect of apolipoprotein В-100: molecular disease basis and clinico-biochemical characteristics of the patients by P. P. Malyshev, A. N. Meshkov, L. A. Kotova, V. V. Kukharchuk

    Published 2007-12-01

    Aim. To identify character and prevalence of apolipoprotein (apo) B-100 gene mutation in patients with clinical diagnosis of heterozygote familial hypercholesterolemia (FH); to describe its phenotypical features in mutation carriers. Material and methods. In 111 patients with clinical diagnosis of h...

    Full description

    Get full text
    Article
  17. 17

    Bioinformatics approach to processing data from high-throughput sequencing of small RNA molecules by A. A. Zharikova, Yu. V. Vyatkin, A. V. Kiseleva, A. N. Meshkov

    Published 2025-01-01

    High-throughput sequencing of small ribonucleic acid (RNA) molecules is widely used to search for markers of various diseases, as well as to study the regulation of gene expression. The data processing protocol consists of many stages, including the stages of analyzing the initial data quality and s...

    Full description

    Get full text
    Article
  18. 18

    Familial dysbetalipoproteinemia: highly atherogenic and underdiagnosed disorder by A. V. Blokhina, A. I. Ershova, A. N. Meshkov, O. M. Drapkina

    Published 2021-10-01

    Familial dysbetalipoproteinemia (FD) is a genetic, highly atherogenic disorder. The penetrance of FD depends on the patient’s lifestyle and concomitant diseases. Despite the fact that FD was described almost half a century ago, it is still insufficiently studied and is extremely rarely diagnosed. In...

    Full description

    Get full text
    Article
  19. 19

    Phenotypical characteristics of severe hypertriglyceridemia by T. V. Chepetova, A. N. Meshkov, T. A. Rozhkova, P. P. Malyshev, V. V. Kukharchuk

    Published 2007-10-01

    Aim. To study clinical course and severe complication development in patients with severe hypertriglyceridemia (HTG), >10 mmol/l. Material and methods. The study included 75 patients aged 21-68 years (mean age 49±11,05 years), examined at the Cardiology Complex in 1982-2006, with verified fas...

    Full description

    Get full text
    Article
  20. 20

    Coronary heart disease development in heterozygotic form of familial hypercholesterolemia by P. P. Malyshev, T. A. Rozhkova, E. Yu. Solovyeva, A. N. Meshkov, V. V. Kukharchuk

    Published 2006-10-01

    Aim. To assess coronary heart disease (CHD) and its risk factors (RF) prevalence, as well as their interaction in patients with heterozygotic form of familial hypercholesterolemia (FHCH). Material and methods. The analysis included 200 patients aged 24 years and above, with clinical diagnosis of FHC...

    Full description

    Get full text
    Article